The global single use sensors market size, valued at USD 0.50 billion in 2025, is projected to reach USD 0.58 billion in 2026 and USD 1.92 billion by 2035, representing a CAGR of 14.2% during the forecast period. The biopharmaceutical industry is witnessing an upsurge due to the growing demand for advanced therapeutic drugs that target a broad range of diseases. Several blockbuster drugs, including monoclonal antibodies and cell and gene therapies, require highly controlled bioprocessing technol...

The global protein engineering market, valued at USD 0.85 billion in 2025, is projected to reach USD 0.96 billion in 2026 and USD 3.15 billion by 2035, with a 14.1% CAGR during the forecast period 2026 to 2035. Driven by the significance offered by protein-based medications, several pharmaceutical companies accelerated their research efforts towards development of novel medicines. It is worth highlighting here that more than 55 protein-based therapies have already been marketed for the treatm...

The tissue engineering market, valued at USD 4.6 billion in 2025, is projected to reach USD 4.9 billion in 2026 and USD 12.7 billion by 2035, with a 11.2% CAGR during the forecast period 2026 to 2035. Over the years, there has been an increase in accidental injuries and diseases that result in tissue or organ damage. According to a research report, nearly 6% of individuals are projected to be affected by chronics wounds across the globe. To address the concern, regenerative medicine and tissue e...

Microbiome refers to the diverse community of microorganisms that inhibit different environments in and on the human body (such as gut, respiratory tract, skin and urogenital tract). In fact, the human microbiome contains about 100 trillion microbes. However, the imbalances in microbiota, also known as dysbiosis, often results in negative health consequences including (but not limited to) anxiety, autism, cancer, diabetes, infectious diseases, inflammatory bowel diseases and obesity. In the abov...

The global in vitro ADME toxicology testing market, valued at USD 4.5 billion in 2025, is projected to reach USD 5.2 billion in 2026 and USD 6.0 billion by 2030, with a 3.9% CAGR during the forecast period 2026 to 2030. The need for improved therapeutic drugs to target a wide range of diseases has heightened the focus on ADME toxicology testing to ensure the efficiency and safety of medicines for human use. Currently, oncology disorders are likely to hold the largest share of the market and are...

The global precision medicine software market size, valued at USD 43 million in 2025, is projected to reach USD 81 million in 2026 and USD 324 million by 2032, representing a CAGR of 26.0% during the forecast period. Precision medicine software is a form of specialized computer applications or programs specifically designed to support the development of personalized treatment in healthcare. Personalized medicine refers to the tailored treatment approach that has been designed on the basis of the...

The oral proteins and peptides market, valued at USD 2.47 billion in 2025, is projected to grow to USD 3.26 billion in 2026 and USD 8.42 billion by 2032, representing a CAGR of 17.1% during the forecast period. The growth of the oral proteins and peptides market is mainly driven by the rising prevalence of chronic diseases such as diabetes, chronic idiopathic constipation, and others. These chronic diseases require daily dose of medicine, sometime multiple dose in a day. Owing to the large size...

The liposome manufacturing market, valued at USD 0.9 billion in 2025, is projected to grow to USD 1.0 billion in 2026 and USD 2.3 billion by 2035, representing a CAGR of 10.1% during the forecast period. Liposome manufacturing involves the production of liposomes, which are small artificial vesicles composed of lipid bilayers. These vesicles are capable of encapsulating drugs or other active molecules within their structure which allow targeted delivery to specific sites within the body. The mar...

The global safety syringe and safety needles market, valued at USD 6.80 billion in 2025, is projected to reach USD 6.90 billion in 2026 and USD 8.90 billion by 2035, representing a CAGR of 2.9% during the forecast period. Given the increasing incidence of needlestick injury among patients, there is a surge in the requirement of safety syringes and needles. Safety needles refer to syringes that are specifically designed to reduce the risk of needlestick injuries and enhance safety to prevent the...

The vaccine adjuvants market, valued at USD 5.26 billion in 2025, is projected to grow to USD 5.51 billion in 2026 and USD 6.08 billion by 2035, representing a CAGR of 1.1% during the forecast period. Presently, an increasing number of vaccines under development are incorporating adjuvants in vaccines owing to various advantages offered by such agents, including improved adaptive response to a vaccine, guiding the type of adaptive response to produce the most effective forms of immunity for each...

The global molecular cloning market for kits is estimated to grow from $3.1 billion in 2025 to $3.6 billion in 2026 and $14.5 billion by 2035, representing a higher CAGR of 16.9% during the forecast period. Further, more than 3,200 patents and 4,000 research articles have been published for DNA cloning technologies in the past few years; this is indicative of the innovative efforts of the stakeholders engaged in molecular cloning market. Driven by the increasing demand for gene therapies and the...

The global cell migration and cell invasion assay market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 3.5 billion by 2035, representing a CAGR of 7.7% during the forecast period. Given their extensive utilization in various drug discovery, tumor study and screening applications, there has been a significant rise in the revenue generation potential associated with cell migration and cell invasion assay kits. The current cell migration and cell invasion...

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Bullous Pemphigoid, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling pric...

Cancer, a life-threatening disease, also has genetic origins, and is considered among the leading causes of death across the globe. In fact, the World Health Organization (WHO) has reported that close to 10 million cancer related deaths annually, across the world. As a result, this disease area is characterized by a significant unmet need for curative interventions; and therefore, considered among the most lucrative opportunity areas for biopharmaceutical developers. Currently, there are over 20...

Cancer, one of the leading causes of death worldwide, claimed close to 10 million lives annually Although there are several treatment options available to control disease progression and keep malignant cells from spreading throughout the body, lasting remission is difficult to achieve. In this context, immunotherapies, a relatively recent addition to the gamut of anticancer interventions, have demonstrated significant promise. Presently, the success rate for CAR T-cell therapies is estimated to...

In 2020, close to 340 million tons of meat was estimated to be produced worldwide. Compared to the early 1960s (~70 million tons), this represents almost a 500% increase. As a result, raising animals for slaughter is estimated to be responsible for close to 15% of global greenhouse gas emissions. Animal farming also requires large areas of land, for grazing, which is often the cause of deforestation efforts. In this context, it is worth highlighting that raising cattle for beef and lamb meat pro...

The women's digital health market is estimated to be worth $2.04 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 18.9% during the forecast period. Females constitute 49.6% of the world

The global aptamers market is estimated to grow from $0.92 billion in 2025 to reach $1.48 billion in 2026 and $12.78 billion by 2035, representing a higher CAGR of 27.0% during the forecast period. Over 100 clinical trials, along with several preclinical studies, have demonstrated the potential of aptamers as a safe and effective treatment modality, owing to their unique characteristics, such as high binding affinity and specificity. Given the various advantages, aptamer-based therapeutics in th...

The report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of GvHD.